Research & Development

Actavis Announces Trial Results

Company reveals outcome of Topline Phase 3 Clinical Trial for Single-Dose DALVANCE' (dalbavancin) in the Treatment of ABSSSI

Revolutionary New Concept of Heart Disease Threatens…

Dr. Rath Research Institute: Revolutionary new concept of heart disease threatens end of global statin market

First-in-Human Phase 1 Trial of MM-141 Demonstrates…

Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting…

BCM-95 Curcumin and BosPure Boswellia in Prevention…

In the first study of its kind, researchers have demonstrated novel and previously unknown mechanisms of action